AIBODY, a Physiology-as-a-Service platform, has signed a collaboration agreement with the German Heart Centre Berlin (DHZB), a medical research institute specialising in cardiovascular disease.
CEO of AIBODY, Richard Littlehales said: “We will begin by creating a comprehensive catalogue of conditions to provide a ‘living’ reference guide for doctors and radiologists to help recognize and define what they are seeing on patient imagery. Our ultimate goal is to build an AI-driven diagnostic device based on creating a ‘digital twin’ of each individual patient’s heart, reflecting their actual physiology and giving the clinical teams a better understanding of that patient’s specific condition and its likely development over time.”
To read the full article, please visit: www.med-technews.com